Literature DB >> 6434428

Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping.

W D Zollinger, E E Moran, H Connelly, R E Mandrell, B Brandt.   

Abstract

A series of murine monoclonal antibodies to serotype 2 and serotype 15 strains of Neisseria meningitidis were produced which were specific for outer membrane proteins of classes 1, 2, 3, and 5. A panel of eight monoclonal antibodies that exhibited a high degree of serotype specificity when reacted with prototype strains of known serotype were selected for study. Each of the corresponding epitopes was localized on a specific outer membrane protein by means of immunoprecipitation, electroblotting, or both. The serotype 2a-, 2b-, and 2c-specific antibodies bound to the class 2 protein, the serotype 15-specific antibody bound to the class 3 protein, two antibodies (3-1-P1.2 and 3-1-P1.16) bound to class 1 proteins, and two antibodies (1-1-P5.1 and 3-1-P5.2) bound to class 5 proteins. Six of these monoclonal antibodies were used in a spot-blot procedure to survey 122 case isolates (groups B, C, Y, and W135) and 363 carrier isolates (all serogroups) for the presence of the 2a, 2b, 2c, 15, P1.2, and P1.16 epitopes. A total of 66% of the case isolates and 30% of the carrier isolates reacted with one or more of the monoclonal antibodies. The use of monoclonal antibodies for serotyping of meningococci appears to be feasible and easy and appears to have significant advantages over the use of polyclonal typing sera.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434428      PMCID: PMC261468          DOI: 10.1128/iai.46.1.260-266.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  New Classification of Neisseria meningitidis by Means of Bactericidal Reactions.

Authors:  R Gold; F A Wyle
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

3.  Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method.

Authors:  C E Frasch; S S Chapman
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Serotyping of meningococci by coagglutination with monoclonal antibodies.

Authors:  L O Frøholm; K Bøvre; E Holten; W D Zollinger
Journal:  NIPH Ann       Date:  1983-12

6.  Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.

Authors:  W D Zollinger; R E Mandrell; J M Griffiss; P Altieri; S Berman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins.

Authors:  R E Mandrell; W D Zollinger
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

8.  Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, Winter 1981-1982.

Authors:  K Bøvre; L O Frøholm; P Gaustad; E Holten; E A Høiby
Journal:  NIPH Ann       Date:  1983-06

9.  Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

10.  Serotypes of Neisseria meningitidis associated with an increased incidence of meningitis cases in the Hamilton area, Ontario, during 1978 and 1979.

Authors:  F E Ashton; J A Ryan; C Jones; B R Brodeur; B B Diena
Journal:  Can J Microbiol       Date:  1983-01       Impact factor: 2.419

View more
  30 in total

1.  Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

Authors:  C Hal Jones; Naglaa Mohamed; Eduardo Rojas; Lubomira Andrew; Johanna Hoyos; Julio C Hawkins; Lisa K McNeil; Qin Jiang; Leonard W Mayer; Xin Wang; Rodica Gilca; Philippe De Wals; Louise Pedneault; Joseph Eiden; Kathrin U Jansen; Annaliesa S Anderson
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

2.  Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.

Authors:  Raymond Sw Tsang; Susan G Squires; Wendell D Zollinger; Fraser E Ashton
Journal:  Can J Infect Dis       Date:  2002-11

3.  Characterization of serogroup A and B strains of Neisseria meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis.

Authors:  E Wedege; D A Caugant; L O Frøholm; W D Zollinger
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

4.  Surface antigen analysis of group B Neisseria meningitis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein.

Authors:  M G Danelli; N M Batoreu; M D Lacerda; C R Ferreira; J D Cardoso; J M Peralta; C E Frasch
Journal:  Curr Microbiol       Date:  1995-09       Impact factor: 2.188

5.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Emergence of a new clone of serogroup C Neisseria meningitidis in São Paulo, Brazil.

Authors:  C T Sacchi; R C Zanella; D A Caugant; C E Frasch; N T Hidalgo; L G Milagres; L L Pessoa; S R Ramos; M C Camargo; C E Melles
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

7.  Redesignation of a purported P1.15 subtype-specific meningococcal monoclonal antibody as a P1.19-specific reagent.

Authors:  E Wedege; D A Caugant; A Musacchio; N B Saunders; W D Zollinger
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

8.  Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile.

Authors:  C Cruz; G Pavez; E Aguilar; L Grawe; J Cam; F Mendez; J Garcia; S Ruiz; P Vicent; I Canepa
Journal:  Epidemiol Infect       Date:  1990-08       Impact factor: 2.451

9.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Typing Neisseria meningitidis by analysis of restriction fragment length polymorphisms in the gene encoding the class 1 outer membrane protein: application to assessment of epidemics throughout the last 4 decades in China.

Authors:  P Zhu; X Hu; L Xu
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.